In the N-substituted benzoylthiourea, C 24 H 23 N 5 OS, the benzoylthiourea unit is non-planar (r.m.s. deviation = 0.126 Å ). The aliphatic part of the tetrahydroquinoline fused-ring system is disordered over two positions in a 0.592 (5):0.408 (5) ratio. The pyridine and pyrrole rings are twisted by 55.2 (1) in order to avoid crowding of their respective substituents. Pairs of molecules are linked by N-HÁ Á ÁN hydrogen bonds, forming centrosymmetric dimers. Furthermore, an intramolecular N-HÁ Á ÁO hydrogen bond stabilizes the molecular conformation. Table 1 Hydrogen-bond geometry (Å , ). Data collection: CrysAlis PRO (Agilent, 2010); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: X-SEED (Barbour, 2001); software used to prepare material for publication: publCIF (Westrip, 2010). -3-[3-cyano-8-methyl-4-(1-methyl-1H-pyrrol-2-yl)-5,6,7,8- 
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Comment
There are several studies on cyanopyridine derivatives as these compounds exhibit useful anticancer and antiviral activities Cocco et al., 2005; El-Hawash et al., 2006) . If these compounds possess a primary amine group, then they can be reacted with phenyl isothiocyanate to yield cyanopyridine-benzoythiourea derivatives, yet another class of medicinal compounds. Because of the ease phenyl isothiocyanate reacts with primary amines, we have in this study used 2-amino-3-cyano-8-methyl-4-(N-methylpyrrolyl)-5,6,7,8-tetrahydroquinoline to synthesize the correponding N-substituted benzoylthiourea (Scheme I).
In the N-substituted benzoylthiourea, C 24 H 23 N 5 OS, the benzoylthiourea portion is somewhat non-planar; the mean plane is aligned at 67.9 (1)° with respect the the mean-plane of the non-planar tetrahydroquinoline fused-ring. An intramolecular N-H···O hydrogen bond appears to prevent further twisting in the benzoylthiourea portion. The aliphatic portion of the tetrahydroquinoline fused-ring is disordered over two positions in a 0.592 (5): 0.408 ratio. The pyridine ring (which has a cyanide substituent) and the pyrrole ring (which has a methyl substitutent) are twisted by 55.2 (1) ° in order to avoid crowding of their respective substituents ( Fig. 1 ). Two molecules are linked by an N-H···O hydrogen bonds to form a centrosymmetric dimer (Table 1) .
Experimental 2-Amino-3-cyano-8-methyl-4-(N-methylpyrrolyl)-5,6,7,8-tetrahydroquinoline (10 mmol), potassium carbonate (20 mmol) in dry acetone (25 ml) was stirred and then treated with phenyl isothiocyanate (12 mmol). The mixture was heated for 10 h; the acetone was removed under pressure and the solid mass dissolved in water. The solution was acidified with 2 N hydrochloric acid. The crude product was purified by recrystallization from ethanol.
Refinement
Carbon-and nitrogen-bound H-atoms were placed in calculated positions [C-H 0.95 to 1.00, N-H 0.88 Å, U iso (H) 1.2-15U eq (C,N)] and were included in the refinement in the riding model approximation.
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